<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The importance of an in-depth understanding about <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> is ultimately to decrease the mortality and morbidity from esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> by early detection of <z:mpath ids='MPATH_160'>metaplasia</z:mpath> and <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and appropriate therapy </plain></SENT>
<SENT sid="1" pm="."><plain>This review summarizes several publications in the past year related to the epidemiology, pathogenesis, screening and surveillance, new methods for detection of <z:mpath ids='MPATH_160'>metaplasia</z:mpath>/<z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and advances in the treatment of <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>RECENT FINDINGS: Patients with <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> are characterized by the presence of risk factors usually indicative of severe types of <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Recent insights into epidemiology and pathogenesis have shown that the risk of high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> may be related to the increasing length of <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo>, size of <z:hpo ids='HP_0002036'>hiatus hernia</z:hpo>, and severity of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The role of smoking and alcohol consumption remains controversial </plain></SENT>
<SENT sid="5" pm="."><plain>Increasing the number of biopsies by repeat standard endoscopy can enhance the yield of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> in patients with suspected short-segment <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Costs of surveillance using standard endoscopy and random biopsies would be very high and using special techniques to target specific areas could ultimately help in cost reduction </plain></SENT>
<SENT sid="7" pm="."><plain>Emerging data on new techniques and technology such as vital staining with <z:chebi fb="11" ids="6872">methylene blue</z:chebi> and <z:chebi fb="0" ids="15430">protoporphyrin</z:chebi> fluorescence can increase the yield of <z:mpath ids='MPATH_160'>metaplasia</z:mpath> and <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Biomarkers studies have revealed that p53 mutation by the loss of heterozygosity can help detect patients with low and high risk for <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Studies thus far have been unclear whether acid suppression alone can impact the malignant progression in <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> patients </plain></SENT>
<SENT sid="10" pm="."><plain>Inhibition of cyclooxygenase by aspirin or <z:chebi fb="2" ids="35475">nonsteroidal anti-inflammatory drugs</z:chebi> may be a promising chemoprevention strategy against <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> development as shown in some recent studies </plain></SENT>
<SENT sid="11" pm="."><plain>Nonsurgical treatment by photodynamic therapy or mucosal resection may be a less invasive and organ-sparing option for some patients with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and early <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>SUMMARY: In the past year we have made major strides in our knowledge of this <z:e sem="disease" ids="C0850639" disease_type="Neoplastic Process" abbrv="">premalignant lesion</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>Recent studies have shed light in a better understanding of the epidemiology of <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo>, including clinical and endoscopic factors associated with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and various biomarkers that would identify patient subsets with low and high risk for <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>This will eventually have significant implications on the screening, surveillance, and treatment of the disease </plain></SENT>
<SENT sid="15" pm="."><plain>Advanced endoscopic therapies including mucosectomy or photodynamic therapy may be emerging options in patients with intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
</text></document>